Many public offerings were absent from the Celgene issuance?

Tonghuashun data shows that since the beginning of time, 1,654 new funds have been announced. It is worth noting that since last year, 24 of the fund companies that have opened have "not issued a fund." Below, the editor brings together a number of public offerings that are absent from the new base issuance. Let’s take a look at them together. I hope it can bring reference.

Many public offerings were absent from Celgene issuance

Institutions that were absent from this round of Celgene issuance include smaller Mingya Fund, Huachen Future Fund, Kaishi Fund, and Yimin Funds, etc., as well as securities firms with public offering business qualifications such as Guodu Securities, Huaxin Securities, First Venture Securities, Huachuang Securities, etc. The last time the well-known public offering Ruiyuan Fund established a new product was in December 2021, and there are still only 3 products; the old public offering Xinhua Fund only had 2 bond funds last year and they were still established with E-class shares; the larger CITIC Prudential Fund During this period, only a few funds with Qianhai Open Source Fund’s Class C or Class E shares were established. In addition, Haifutong Fund and Xinjiang Qianhai United Fund have not reported any products since January last year.

The public offering situation of several unissued products is relatively special, such as West China Fund and Minsheng Fund. These two securities firms have not opened for public offering after obtaining licenses.

Public information shows that West China Fund submitted application materials for a public offering license in November 2020 and was established in November 2021. This is the first public offering institution in Sichuan Province. The registered capital of West China Fund is RMB 100 million. West China Securities invested RMB 76 million, accounting for 76% of the capital. Li Bengang, general manager of West China Fund, invested RMB 24 million and holds 24% of the shares. According to the approval of the China Securities Regulatory Commission, West China Securities should complete the establishment of the West China Fund within 6 months from the date of approval, pay the capital in full, elect directors and supervisors, and appoint senior managers; West China Fund should obtain a securities and futures business license from Public fund products shall be issued within 6 months from the date of the announcement.

Many public offerings were absent from the issuance of Celgene

However, there has been no news of the opening of West China Fund. Although it has not yet launched new products, West China Fund has actively carried out research work. According to public information, the companies investigated by West China Fund since last year include Eston, Xinjinggang, Sunong Bank, Xinlai Yingcai, Xiangxin Technology, etc.

Minsheng Fund obtained its public offering license much earlier than West China Fund. It was approved in February 2020 and established in June of the same year. However, due to operating difficulties, Oceanwide Holdings put the shares of Minsheng Securities up for auction, and Minsheng Fund is a wholly-owned subsidiary of Minsheng Securities.

Some new public offerings launched later than West China Fund and Minsheng Fund were issued rapidly. The personal public offering Quanguo Fund was officially established in February last year. It began to raise its first dedicated account product at the end of July of the same year, and the first public offering fund was launched in October. In addition, the announcement also showed that the first product of the foreign-owned public offering Neuberger Berman Fund established in July 2021 has been launched on sale this Monday.

Catch stocks with continuous daily limit

In the mid-line stock selection skills, if you want to make a mid- to long-term layout, you have to look at the current market situation. You can refer to the annual line of the market index (250-day line) ) and the half-year line (120-day line). If the trend is above the annual line and the half-year line, it means that it is not a bear market currently. In the face of national policies and the overall decline of the stock market, investors should not take chances to rush for a rebound or choose to buy, but should take advantage of the trend to clear positions and wait and see. If the stock market rises sharply, you should enter with the trend and hold shares in the medium term.

Midline stock selection should be comprehensively analyzed from six aspects: K-line shape, technical indicators, relative price, company fundamentals, market trend, and stock theme. Some stocks with high P/E ratios and prices much higher than their intrinsic value should be abandoned.

As for how to catch stocks with continuous daily limit? The starting stock price has increased by more than 6%; it must be "increased"; the greater the increase, the stronger the trend and the more favorable it is. Among the key conditions for the daily limit, it is best to open higher by 2 to 3 points and open lower by no more than 2 points; do not increase the volume during the decline, otherwise there will be suspicion of shipments; the closing price should close near yesterday's closing price. It is best to form a gap.